Cerata has achieved a leadership position in the field of APIs because of various factors. We've implemented backward integration to secure essential starting materials, established dedicated production blocks with substantial batch capacities, and proactively built significant production capacity in advance.
Our commitment to being a reliable API manufacturer remains unwavering. We strive to complement our customers by delivering consistent quality and competitive pricing. Our dedication to this role is evident through ongoing process improvements, engineering efficiencies, and the integration of Green Chemistry principles, all aimed at providing uniform, high-quality APIs to customers worldwide and it makes us the Leading API manufacturer in the international pharma industry.
We export our API and Medicines products from India to international markets like Asia, Africa, the Middle East, Europe and America.
API manufacturing facilities of Cerata Pharmaceuticals have undergone rigorous audits by Global Regulatory Authorities, leading Big Pharma and Multi-National Companies, Statutory Authorities, and Global Environmental, Health, and Safety teams. These audits underscore our commitment to meeting and exceeding industry standards.
We take pride in providing the global pharmaceutical industry with reliable, cGMP-quality, and value-driven solutions across a range of products. Our dedication to quality and excellence is central to our mission, ensuring that we consistently deliver solutions that meet the highest industry standards.